Back to top
Live:
Coronavirus Updates

First US Patients Dosed in COVID-19 mRNA Vaccine Clinical Trial

Pfizer Inc. and BioNTech SE have announced a new clinical trial that will test the ability of four experimental messenger RNA (mRNA) vaccine candidates to prevent infection with SARS-CoV-2, the virus that causes COVID-19. The trial in the United States will be at the NYU Grossman School of Medicine and the University of Maryland.

In Germany — where BioNTech has its headquarters — the companies launched a similar trial with the vaccine (called BNT162) last month, dosing the first subjects in the German trial in late April.

The vaccines being studied are all part of a class called mRNA vaccines. These types of vaccines are made up of viral messenger RNA, genetic material similar to DNA that instructs cells to make new proteins.

A successful vaccine teaches the immune system to recognize microbial invaders for future encounters. Two of the study vaccines contain viral mRNA with instructions for the "spike protein." This protein is used by SARS-CoV-2 to attach to human cell surfaces and invade human cells. The other two vaccines contain viral mRNA with instructions for receptor-binding domains, regions of the spikes that help attach the virus to human cells. By including the viral instructions for the spike protein and receptor-binding domains, the vaccines could allow our bodies to recognize and destroy important viral components early.

The initial phase of the study will test safety, dosing and the number of doses needed by midsummer with 360 healthy participants. Patients will receive either 1 or 2 doses of one of the vaccines or a placebo (saline solution). Participants will be split into two age groups: 18 to 65 years old and 65 to 85 years old. Younger adults will be tested first, and when there is initial evidence of safety, older adults will be tested.

Mark J. Mulligan, M.D., is the director of the Division of Infectious Diseases and Immunology and the Vaccine Center at NYU Langone Health. "Vaccines have always been our most effective weapons to protect the health of the public from infectious disease threats, which is why it's so important to study these candidates closely," he said in a press release. Further phases of the trial will determine if these vaccines will be effective in the global fight against COVID-19.

Read more about the trial.

In our latest HealthDay Now interview, Dr. Anton Porsteinsson, a principal investigator for the Biogen aducanumab trial, and Dr. Ken Lin, a primary care physician, discuss the controversial new Alzheimer's drug and whether it will provide any benefit to patients, despite its highly uncertain efficacy and steep cost.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HD Live! Videos

In our latest HealthDay Now, Mabel Jong spoke with Dr. Lori Pierce, president of the American Society of Clinical Oncology and a cancer radiation specialist at the University of Michigan.

Dr. Pierce shared important takeaways from the recently concluded 2021 ASCO annual meeting and discussed why equity was the chosen theme this year.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

In our latest HealthDay Now, Dr. Hina Talib, a pediatrician and adolescent health specialist at the Children's Hospital at Montefiore, debunks myths and common concerns parents may have about giving their children Pfizer's COVID-19 vaccine, which was recently approved for use in children and teens ages 12 and up.

HealthDay Now's Mabel Jong also speaks with Alan Santee, a high school freshman from Massachusetts, about why he didn't hesitate to get vaccinated, and Ethan Lindenberger, a 20-year-old vaccine advocate from Ohio, about his experience having a mom who is anti-vaccine and how kids and parents can approach these conversations.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

Watch our latest HealthDay Now to hear about the state of mental health and why many people fear returning to their social and work lives.

HealthDay's Mabel Jong spoke to Dr. Vivian Pender, president of the American Psychiatric Association, and Sherry Amatenstein, a social worker and therapist who has been dealing with these anxieties herself.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

Watch our latest HealthDay Now as we recap the highlights of the American Association for Cancer Research (AACR) Annual Meeting 2021.

Mabel Jong from our liveblog team speaks with Dr. Antoni Ribas, former president of the American Association for Cancer Research and professor of medicine at UCLA, and Anna Plym, PhD, a postdoctoral research fellow at Brigham and Women's Hospital.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

Watch our latest HealthDay Now as we dive into the latest details on multisystem inflammatory syndrome in children (MIS-C).

Mabel Jong from our liveblog team speaks with Dr. Mary Beth Son, Program Director of Boston Children's Hospital's Rheumatology Program, and Brian Padla, father of James Padla, who has MIS-C.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.


Watch our latest HealthDay Now as we take a look at how living through the COVID-19 pandemic impacts children socially, mentally and emotionally.

One year in, this is their "new normal," but what does that mean for them? From social isolation to remote learning to a loss of structure and normalcy, we discuss how living during the pandemic has both short- and long-term effects on children.

Mabel Jong from our liveblog team speaks with:

  • Dr. Mark Reinecke, Department of Psychiatry & Behavioral Sciences, Northwestern University
  • Tracy Compton, a parent
  • Stephen Guerriero, a teacher
  • Jake Anderson, a student

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Watch our latest HD Live! as we take a look at the COVID-19 pandemic and the vaccination rollout and how they've impacted people of color.

Mabel Jong from our liveblog team speaks with:

  • Tasha Clark-Amar, CEO, East Baton Rouge Council on Aging
  • Jill Ramirez, Executive Director, Latino HealthCare Forum (Austin)
  • Vickie Mays, PhD, Professor, UCLA Fielding School of Public Health

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Watch our latest HD Live! as we take a look at the global COVID-19 vaccination rollout and how the United States rollout compares.

Mabel Jong from our liveblog team speaks with Dr. Ran Balicer of Clalit Health Services and Dr. Arnold Monto of University of Michigan School of Public Health.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.